Mobile

A trial looking at a new drug called AG-014699 for breast and ovarian cancer in people with gene faults

Mise à jour : Il y a 5 ans
Référence : EUCTR2006-002348-27

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

1) To determine whether AG-014699 has antitumour activity in locally advanced or metastatic breast and advanced ovarian cancer shown to express the BRCA 1 or 2 mutations 2) To evaulate the toxicity of treatment with AG-014699 in these populations.

Critère d'inclusion

  • advanced or metastatic breast or ovarian carcinoma (proven carrier of a mutation in BRCA1 or 2 gene)

Liens